Alghabra v. CVS Pharmacy CA4/1

California Court of Appeal·Decided March 18, 2013·No. D059334·Unpublished

Opinion

Filed 3/18/13 Alghabra v. CVS Pharmacy CA4/1 NOT TO BE PUBLISHED IN OFFICIAL REPORTS California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

COURT OF APPEAL, FOURTH APPELLATE DISTRICT DIVISION ONE

STATE OF CALIFORNIA

MAHER ALGHABRA, D059334 Plaintiff and Appellant,

v. (Super. Ct. No. 37-2009-00104678-

CU-OE-CTL)

CVS PHARMACY, INC., et al.,

Defendants and Respondents.

APPEAL from a judgment of the Superior Court of San Diego County, John S.

Meyer, Judge. Affirmed.

Plaintiff Maher Alghabra appeals from a judgment entered after the trial court granted summary judgment in favor of defendants CVS Pharmacy, Inc. (CVS); Garfield Beach CVS, LLC; CVS RX Services, Inc.; and Sylvester Arcaro (collectively "defendants") on Alghabra's first amended complaint alleging wrongful termination in violation of public policy and related claims. Alghabra contends the trial court erred in granting summary judgment based on defendants' purported statutory immunity from

liability for the reporting of evidence of prohibited conduct by a pharmacist to the California State Board of Pharmacy (BOP). (Bus. & Prof. Code, § 4104.) He also contends he presented admissible evidence raising a triable issue of fact as to whether his employment was terminated in retaliation for his engaging in the protected activity of reporting to federal authorities suspicious activity involving the cash purchase of OxyContin by patients on welfare, and complaining to his pharmacy supervisor that the store manager was sending him and other pharmacy employees sexually explicit text messages. We conclude the court correctly granted defendants' motion for summary judgment because, in opposing the motion, Alghabra did not present sufficient evidence to raise a triable issue of fact as to the causal connection between his termination and his alleged protected activity.

I

FACTUAL AND PROCEDURAL BACKGROUND Alghabra, a licensed pharmacist, began his employment with CVS as a pharmacy manager or "pharmacist-in-charge" (PIC) at CVS "Store No. 8842" in December 2006. During his employment with CVS, defendant Sylvester Arcaro was Alghabra's pharmacy supervisor, Robert Wiltfang was CVS's regional loss prevention manager, and Marshall Hayde was the district manager who supervised Arcaro and the nonpharmacy employees of Store No. 8842. During his year of employment with CVS, Alghabra brought about a substantial increase in pharmacy sales at Store No. 8842.

In September 2007, Alghabra contacted the San Diego RxNet task force to report suspicious activity he had observed in the purchase of the drug OxyContin for cash by

several pharmacy customers of Store No. 8842 who were welfare (Medi-Cal) recipients. Alghabra provided an agent of the federal Drug Enforcement Agency (DEA) copies of the suspicious prescriptions and the identities of certain customers whose prescriptions he believed had been forged. On September 21, 2007, Arcaro sent Wiltfang an e-mail message reporting that Alghabra had informed him about the suspected forged prescriptions and cash payments for OxyContin by patients who "appear homeless." Arcaro's message concluded: "[Alghabra] has reported to RxNet, but if you could follow up, I would appreciate it. This is bad." On November 13, 2007, Alghabra sent Arcaro an e-mail in which he identified three Medi-Cal patients who were willing to pay cash for OxyContin prescriptions and stated, "This is a continuation for an Oxycontin diversion scheme." He asked Arcaro to forward the information to the DEA agent in charge of the case. Arcaro replied to Alghabra's e-mail the same day, stating, "I know you won[']t read this for a couple of days — but nice job!" Arcaro instructed Alghabra and other pharmacists to continue to fill the prescriptions in question, but to exercise caution by calling the providers to verify that the prescriptions were legitimate.

In late October 2007, Alghabra and pharmacy employees under his supervision began receiving sexually explicit text messages on their cell phones from Carlos Salorio, the manager of Store No. 8842. Around November 1, 2007, Alghabra sent Arcaro an e-mail message complaining about the inappropriate text messages that Salorio and a photo clerk named Abbey were sending to Alghabra and other pharmacy employees. Arcaro turned the e-mail over to Hayde because Salorio and Abbey were under Hayde's, rather than Arcaro's, supervision. Arcaro told Alghabra that he and Hayde were looking

into the matter. On November 21, 2007, Alghabra complained to Arcaro in an e-mail that Salorio was "text messaging 24/7 to the employees in the Pharmacy on inappropriate materials and [that] Abby [sic] (photo staff is also involved)." Arcaro replied, "Thanks for the focus on this."

In late October or early November of 2007, during a routine inspection of pharmacy documents at Store No. 8842, Arcaro discovered discrepancies that suggested a customer was picking up multiple refills of hydrocodone, a narcotic drug and controlled substance, on refill prescriptions bearing the same number. Multiple pick-ups of the same refills at the same price suggested that the pharmacy was dispensing more medication to the customer than his prescriptions allowed. Arcaro discussed his discovery with Hayde and Wiltfang.

Arcaro, Hayde, Wiltfang, and another pharmacy employee went into the pharmacy on two different nights after the store was closed to further investigate the questionable hydrocodone refills. Salorio viewed store surveillance videos of the after-hours investigations and testified at deposition that he viewed Arcaro, Hayde, Wiltfang and the other employee who accompanied them remove several trash bags from the pharmacy that appeared to be three-quarters full, but he did not know what was in the bags.1

1 Alghabra states in his opening brief, as he stated in his opposition to the summary judgment motion, that this after-hours entry into the pharmacy and removal of trash bags occurred on November 26, 2007. However, he does not cite any evidence in the record showing the date it occurred.

Wiltfang testified that they made copies of documents related to the refill transactions in question, including prescription logs and prescriptions.

Based on their investigation, Arcaro and Wiltfang concluded that prescriptions were missing from the Store No. 8842 pharmacy and that Alghabra and employees under his supervision had illegitimately dispensed multiple refill prescriptions. On November 28, 2007, Wiltfang contacted a DEA agent he had worked with in the past and told her that Alghabra was fraudulently creating prescriptions and dispensing hydrocodone to a particular customer. He and Arcaro later met with DEA agents to discuss their investigation and the documents they had copied. Because the DEA was conducting its own investigation, Arcaro and Wiltfang discontinued their investigation. DEA agents told them not to speak with Alghabra about their findings while the DEA's investigation was pending.

On December 15, 2007, Alghabra came in to work on a scheduled day off at Arcaro's request. After he arrived, DEA agents arrested him and took him into custody. The DEA did not consult anyone at CVS before deciding to arrest Alghabra. The following day, Alghabra sent an e-mail to Arcaro stating: "This is my resignation as of today please put in- and [FedEx] my final paycheck and vacation check . . . ."2

2 Alghabra testified at deposition that Arcaro fired him when he was arrested and that he sent the December 16, 2007 e-mail to "satisfy [his] self-esteem and ego after [he] was terminated and fired." Defendants dispute that Arcaro fired Alghabra, but for purposes of their summary judgment motion and this appeal, they assume Alghabra was terminated for misconduct.

Free access — add to your briefcase to read the full text and ask questions with AI

Alghabra v. CVS Pharmacy CA4/1, (Cal. Ct. App. 2013).

Alghabra v. CVS Pharmacy CA4/1 (Alghabra v. CVS Pharmacy CA4/1) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Mato v. Baldauf
267 F.3d 444 (Fifth Circuit, 2001)
McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
St. Mary's Honor Center v. Hicks
509 U.S. 502 (Supreme Court, 1993)
Wells v. Colorado Department of Transportation
325 F.3d 1205 (Tenth Circuit, 2003)
Doebele v. Sprint/United Management Co.
342 F.3d 1117 (Tenth Circuit, 2003)
Gonzalez v. El Dia, Inc.
304 F.3d 63 (First Circuit, 2002)
Harris v. City of Santa Monica
294 P.3d 49 (California Supreme Court, 2013)
Reeves v. Sanderson Plumbing Products, Inc.
530 U.S. 133 (Supreme Court, 2000)
Foley v. Interactive Data Corp.
765 P.2d 373 (California Supreme Court, 1988)
Burgess v. Superior Court
831 P.2d 1197 (California Supreme Court, 1992)
Crosier v. United Parcel Service, Inc.
150 Cal. App. 3d 1132 (California Court of Appeal, 1983)
Kerr v. Rose
216 Cal. App. 3d 1551 (California Court of Appeal, 1990)
Tan v. California Federal Savings & Loan Ass'n
140 Cal. App. 3d 800 (California Court of Appeal, 1983)
Nadaf-Rahrov v. the Neiman Marcus Group, Inc.
166 Cal. App. 4th 952 (California Court of Appeal, 2008)
Mills v. U.S. Bank
166 Cal. App. 4th 871 (California Court of Appeal, 2008)
DeJung v. Superior Court
169 Cal. App. 4th 533 (California Court of Appeal, 2008)
Reyes v. Kosha
76 Cal. Rptr. 2d 457 (California Court of Appeal, 1998)